📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-11 16:56
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
10 announcements match the current filters (relevance ≥ 5).
Q1 FY27 Results: Revenue up 7.9% YoY to ₹247.08 Cr; Consolidated PAT at ₹8.92 Cr
Kriti Nutrients reported a 7.9% YoY increase in revenue to ₹247.08 Cr for the quarter ended June 30, 2026. Consolidated Net Profit declined by 6% YoY to ₹8.92 Cr, down from ₹9.49 Cr in Q1 FY26, primarily due to higher stock-in-trade purchases and finance costs. However, on a sequential basis, profitability improved significantly by 40% compared to the ₹6.36 Cr reported in Q4 FY26. The company maintains a very low debt-to-equity ratio of 0.04, providing a stable financial base despite thin operating margins.
Confidence: HIGH
What changedThe company has transitioned into the new fiscal year (FY27) with moderate top-line growth but faces slight margin compression compared to the previous year's first quarter.
Why it mattersAs a leader in the branded refined soya oil segment in Central India, the company's performance is a bellwether for consumer demand and raw material pricing in the solvent extraction industry.
Revenue (Q1 FY27): ₹247.08 CrConsolidated PAT (Q1 FY27): ₹8.92 CrYoY Revenue Growth: 7.87%QoQ PAT Growth: 40.25%Debt-to-Equity Ratio: 0.04
📅 Short termThe stock may see neutral movement as the market weighs the healthy sequential profit recovery against the slight year-on-year decline in earnings.
📈 Long termLong-term value creation depends on increasing the share of high-margin value-added products in food and pharma categories and reducing geographic concentration.
⚠ Risk flags
- Raw material price volatility (soya seeds)
- Geographic concentration in Central India
- Thin operating margins (4.7% TTM)
Key Highlights
Revenue from operations reached ₹247.08 Cr, a 7.9% increase over ₹229.04 Cr in Q1 FY26.
Consolidated Net Profit stood at ₹8.92 Cr for the quarter, compared to ₹9.49 Cr in the year-ago period.
Cost of materials consumed accounted for 81.4% of total revenue at ₹201.08 Cr.
Consolidated EPS for the quarter was ₹1.78, down from ₹1.89 in Q1 FY26 but up from ₹1.27 in Q4 FY26.
Finance costs doubled YoY to ₹23.81 lakhs from ₹11.54 lakhs, though they remain low in absolute terms.
👀 What to Watch
Monitor the company's ability to pass on raw material price increases in the soya meal segment and the execution of its expansion into Rajasthan and Uttar Pradesh.
Kriti Nutrients Q1 FY27: Revenue Grows 7.9% YoY to ₹247 Cr, PAT Dips 6% to ₹8.92 Cr
Kriti Nutrients reported a steady 7.9% YoY increase in revenue from operations to ₹247.08 Cr for the quarter ended June 30, 2026. However, consolidated net profit saw a 6% YoY decline to ₹8.92 Cr, down from ₹9.49 Cr in the year-ago period, likely due to higher input costs. Sequentially, while revenue dipped 3.2% from Q4 FY26, profitability improved significantly from the ₹6.36 Cr reported in the previous quarter. The company continues to operate with a very low debt-to-equity ratio of 0.04.
Confidence: HIGH
What changedThe company released its first-quarter results for FY27, showing moderate top-line growth but a slight contraction in year-on-year profitability.
Why it mattersAs a leader in branded refined soya oil in Central India, the results reflect the company's resilience in a commodity-linked business, though thin margins remain a structural characteristic of the solvent extraction industry.
Revenue (Q1 FY27): ₹247.08 CrConsolidated PAT (Q1 FY27): ₹8.92 CrRevenue vs TTM Revenue: 26.81%YoY Revenue Growth: 7.87%QoQ PAT Growth: 40.25%
📅 Short termThe stock may see neutral to slightly cautious sentiment as the YoY profit decline offsets the revenue growth, though the sequential recovery in PAT is encouraging.
📈 Long termLong-term value creation depends on increasing the share of high-margin value-added products in food and pharma categories and reducing geographic concentration.
⚠ Risk flags
- Raw material price volatility (soya seeds)
- Thin operating margins (4.7%)
- Geographic concentration in Madhya Pradesh
Key Highlights
Revenue from operations increased 7.87% YoY to ₹247.08 Cr from ₹229.04 Cr.
Consolidated Net Profit declined 6.05% YoY to ₹8.92 Cr compared to ₹9.49 Cr in Q1 FY26.
Total expenses rose to ₹237.03 Cr, up from ₹219.22 Cr in the corresponding quarter last year.
Standalone EPS for the quarter stood at ₹1.81, slightly down from ₹1.84 YoY.
Finance costs increased to ₹23.81 lakhs from ₹11.54 lakhs YoY, though remaining low in absolute terms.
👀 What to Watch
Investors should monitor the company's operating margins (TTM OPM 4.7%) and its ability to pass on soya seed price fluctuations. The execution of geographical expansion into Rajasthan and Uttar Pradesh remains the key long-term growth driver to watch.
Kriti Nutrients Submits Audited FY26 Financial Results with Clean Audit Report
Kriti Nutrients Limited has submitted its audited standalone and consolidated financial results for the fiscal year ended March 31, 2026. The statutory auditors, M Mehta & Company, have issued an unmodified opinion, confirming that the financial statements provide a true and fair view of the company's performance. The Board of Directors approved these results in a meeting held on May 5, 2026, which concluded at 5:10 P.M. While the specific numerical data table was not included in this cover letter, the clean audit report is a positive sign for financial transparency.
Key Highlights
Audited standalone and consolidated financial results for FY 2025-26 approved on May 5, 2026.
Statutory auditors issued a clean/unmodified opinion with no qualifications or modifications.
Board meeting for result approval commenced at 2:30 P.M. and concluded at 5:10 P.M.
Results prepared in full compliance with Ind AS and SEBI Regulation 33(3)(d).
Company is in the process of filing results in XBRL format and publishing in English and Hindi newspapers.
👀 What to Watch
Investors should review the detailed Profit & Loss and Balance Sheet statements once the full numerical tables are available to assess revenue and margin growth. The clean audit report confirms the reliability of the company's financial reporting for the fiscal year.
Kriti Nutrients Board Recommends No Dividend for FY 2025-26
Kriti Nutrients Limited has announced that its Board of Directors, in a meeting held on May 5, 2026, decided not to recommend any final dividend for the financial year 2025-26. This follows a prior notification on April 28, 2026, where the board had scheduled a meeting to consider a potential dividend payout. The company's equity shares have a face value of Re. 1 each. The decision to skip the dividend suggests a focus on capital preservation or reinvestment of profits back into the business operations.
Key Highlights
Board of Directors met on May 5, 2026, to discuss dividend recommendation for FY 2025-26.
No final dividend recommended for equity shares with a face value of Re. 1/- each.
The announcement follows a previous intimation of dividend consideration dated April 28, 2026.
Decision reflects a shift in capital allocation strategy for the 2025-26 financial year.
👀 What to Watch
Investors should review the upcoming full-year financial results to understand the company's cash flow position and reasons for skipping the dividend. Monitor management commentary for any planned capital expenditures or debt reduction that may justify the retention of earnings.
Kriti Nutrients Re-appoints Shiv Singh Mehta as CMD; Elevates Saurabh Mehta to JMD
Kriti Nutrients has announced the re-appointment of Shri Shiv Singh Mehta as Chairman and Managing Director for a three-year term starting January 2027. Simultaneously, Mr. Saurabh Singh Mehta has been re-designated as Joint Managing Director effective May 5, 2026, with a further three-year term approved from August 2027. These appointments ensure leadership continuity for the company, which is part of the Rs. 1,500 crore turnover Kriti Group. The decisions are subject to shareholder approval at the next General Meeting.
Key Highlights
Shri Shiv Singh Mehta re-appointed as CMD for 3 years effective Jan 12, 2027.
Mr. Saurabh Singh Mehta elevated to Joint Managing Director (JMD) effective May 5, 2026.
Saurabh Singh Mehta's tenure as JMD extended for 3 years starting Aug 1, 2027.
The Kriti Group reports an aggregate annual turnover of approximately Rs. 1,500 crore.
Appointments are pending final approval from members in the ensuing General Meeting.
👀 What to Watch
The re-appointments suggest a continuation of the current strategic direction under the existing promoter family. Investors should monitor the company's performance consistency under this stable leadership.
Kriti Nutrients FY26 Results: Board Skips Final Dividend, Re-appoints MD for 3 Years
Kriti Nutrients has approved its audited financial results for the quarter and year ended March 31, 2026. The Board has notably decided not to recommend any final dividend for the financial year 2025-26, which may impact short-term investor sentiment. To ensure leadership continuity, the company re-appointed Mr. Shiv Singh Mehta as Chairman and Managing Director for a three-year term starting in 2027. Additionally, Mr. Saurabh Singh Mehta has been elevated to the position of Joint Managing Director.
Key Highlights
Audited standalone and consolidated financial results for FY26 approved with an unmodified auditor opinion.
No final dividend recommended for the financial year 2025-26 on equity shares of Re. 1/- each.
Mr. Shiv Singh Mehta re-appointed as Chairman and MD for a 3-year term effective January 12, 2027.
Mr. Saurabh Singh Mehta re-designated as Joint Managing Director with a new 3-year term starting August 2027.
The Board meeting concluded with a focus on management stability and routine business agendas.
👀 What to Watch
Investors should analyze the full financial statements to understand why the dividend was skipped despite the audited profits. The management continuity is a positive sign for long-term strategic execution.
Kriti Nutrients Shareholders Approve MOA Changes for Solar Power with 99.96% Majority
Kriti Nutrients Limited has received shareholder approval to amend its Memorandum and Articles of Association to include power generation activities. This strategic move allows the company to establish solar power facilities for captive use, following directions from the Madhya Pradesh Power Transmission Company Limited. The resolutions were passed with a near-unanimous majority of 99.9555% during the EGM held on March 20, 2026. This initiative is expected to enhance energy efficiency and reduce long-term power costs for the company's manufacturing operations.
Key Highlights
Special resolution passed to add Clause 35A to the MOA, enabling the company to generate and distribute power from renewable sources like solar and wind.
The proposal received 3,34,19,621 votes (99.9555%) in favor, indicating strong shareholder support for the green energy transition.
The initiative focuses on captive power generation to meet requirements set by the Madhya Pradesh Power Transmission Company Limited.
The EGM was conducted via video conferencing with 47 members participating, comfortably meeting the quorum requirement of 30.
👀 What to Watch
This is a positive development for long-term cost management; investors should track the implementation timeline and capital expenditure involved in the solar power setup.
Kriti Nutrients Approves MOA and AOA Changes to Enter Power Generation Sector
Kriti Nutrients Limited conducted an Extraordinary General Meeting (EGM) on March 20, 2026, to approve significant changes to its business objects. Shareholders voted on altering the Memorandum and Articles of Association to permit the company to engage in power generation from conventional and renewable sources like solar and wind. This strategic move enables the company to establish power plants for both captive consumption and commercial sale. The meeting saw participation from 47 members, and the final voting results will be disclosed within two working days.
Key Highlights
EGM held on March 20, 2026, with 47 members present, meeting the quorum requirement of 30.
Approved insertion of Clause 35A in the MOA to include power generation, transmission, and distribution.
Authorized the Board via new Article 92 in the AOA to acquire or manage electricity generation plants.
Scope includes diverse energy sources such as solar, wind, biomass, and hydrogen for captive or external use.
Voting results to be declared within 2 working days from the meeting conclusion.
👀 What to Watch
Investors should monitor the upcoming voting results and look for management commentary on planned CAPEX for power infrastructure. This move suggests a focus on operational efficiency through captive power and potential diversification into the energy sector.
Kriti Nutrients to Seek Shareholder Approval for Power Generation Business Expansion at EGM
Kriti Nutrients Limited has scheduled an Extra Ordinary General Meeting (EGM) on March 20, 2026, to seek shareholder approval for significant amendments to its Memorandum and Articles of Association. The company intends to expand its business scope to include the generation, distribution, and sale of power from conventional and renewable sources such as solar, wind, and biomass. This move allows the company to establish power plants for both captive consumption to reduce operational costs and for commercial sale to external parties. The meeting will be conducted via video conferencing, reflecting a strategic pivot towards energy infrastructure.
Key Highlights
EGM scheduled for March 20, 2026, to approve alterations in the Memorandum of Association (MOA) and Articles of Association (AOA).
Proposed insertion of Clause 35A in MOA to enable business in solar, wind, biomass, and hydrogen energy sectors.
New Article 92 to be added to AOA, authorizing the Board to acquire or build power facilities for captive or commercial use.
The expansion covers a wide range of technologies including thermal, hydel, and fuel cell technology.
Facility for participation at the EGM through VC/OAVM will be available for up to 1,000 members.
👀 What to Watch
Investors should view this as a strategic move towards energy self-sufficiency and potential revenue diversification; monitor future announcements regarding specific CAPEX for power projects.
Kriti Nutrients Q3 FY26 Consolidated Net Profit Rises 11% YoY to ₹9.16 Crore
Kriti Nutrients reported a strong 29.7% YoY growth in consolidated revenue for Q3 FY26, reaching ₹224.31 crore. Consolidated net profit for the quarter grew by 11% YoY to ₹9.16 crore, showing recovery from previous quarters. However, the nine-month (9M) profit remains 14.1% lower than the previous year at ₹27.54 crore, reflecting margin pressures earlier in the fiscal year. The company maintains a stable balance sheet with minimal finance costs of ₹11.75 lakhs for the quarter.
Key Highlights
Consolidated Revenue from Operations grew 29.7% YoY to ₹224.31 crore in Q3 FY26.
Consolidated Net Profit increased 11% YoY to ₹9.16 crore from ₹8.25 crore in Q3 FY25.
9M FY26 Revenue reached ₹666.28 crore, up 24.7% compared to ₹534.28 crore in 9M FY25.
Cost of materials consumed rose significantly to ₹181.85 crore in Q3 FY26 vs ₹135.80 crore in Q3 FY25.
Consolidated EPS for the quarter improved to ₹1.83 from ₹1.65 in the year-ago period.
👀 What to Watch
The quarterly performance shows healthy top-line growth and a recovery in bottom-line margins compared to the previous quarter. Investors should monitor raw material price trends as they remain the largest cost component impacting overall profitability.
